Reported relationships
Latest disclosed role at each company.
| Company | Last reported as | Report date | Published |
|---|---|---|---|
| CorMedix Inc.CRMD · Entity 5280 | Director | January 26, 2026 | January 27, 2026 |
Disclosed balances
About these balances
Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.
CorMedix Inc.
Report date January 26, 2026 · Filed January 27, 2026
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common StockSEC Table I · non-derivative | Direct | 68,926 |
Reported balance
After 2026-01-26 transaction · row 1
1 source rowRow 1 · 2026-01-26 · Grant · Acquired 30,453 · Balance 68,926 F1: These shares represent restricted stock units issued on January 26, 2026. Each restricted stock unit represents the right to receive one share of CorMedix Inc. common stock. These restricted stock units will vest in full on January 26, 2027, subject to continued service on the vesting date. |
Filing footnotes · ownership attribution and instrument terms
F1: These shares represent restricted stock units issued on January 26, 2026. Each restricted stock unit represents the right to receive one share of CorMedix Inc. common stock. These restricted stock units will vest in full on January 26, 2027, subject to continued service on the vesting date.
Transaction history
JSON APIPurchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Company | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| January 26, 2026 Filed Jan 27, 2026 21:30 UTC | CorMedix Inc. CRMD · Entity 5280 | GrantCommon Stock | 30,453 | $0.00 | $0.00 |
DisclosureSEC source: 0001213900-26-008476 · ownership.xml · nonDerivative · entry 1 Dillione Janet · CIK 0001489798 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 68,926 F1 · price: These shares represent restricted stock units issued on January 26, 2026. Each restricted stock unit represents the right to receive one share of CorMedix Inc. common stock. These restricted stock units will vest in full on January 26, 2027, subject to continued service on the vesting date. Read SEC document |
| January 21, 2026 Filed Jan 22, 2026 21:30 UTC | CorMedix Inc. CRMD · Entity 5280 | SaleCommon Stock | 10,000 | $6.88 | $68,800.00 |
DisclosureSEC source: 0001213900-26-006876 · ownership.xml · nonDerivative · entry 1 Dillione Janet · CIK 0001489798 · Director 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 38,473 F1 · price: This transaction was executed in multiple trades at prices ranging from $6.85 to $6.90, inclusive. The price reported in Column 4 is a weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the Issuer or a security holder of the Issuer full information regarding the number of shares and prices at which the transactions were effected Read SEC document |
| December 09, 2025 Filed Dec 11, 2025 08:38 UTC | CorMedix Inc. CRMD · Entity 5280 | Exercise / conversionStock Option (Right to Buy Common Stock) · Derivative | 15,000 | $0.00 Strike: $5.63 | $0.00 |
DisclosureSEC source: 0001213900-25-120378 · ownership.xml · derivative · entry 5 Dillione Janet · CIK 0001489798 · Director 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 15,000 shares Expires 2030-02-25 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · derivative.exercise_date: These options were granted on 02/25/2020. These options are fully vested. Read SEC document |
| December 09, 2025 Filed Dec 11, 2025 08:38 UTC | CorMedix Inc. CRMD · Entity 5280 | Exercise / conversionStock Option (Right to Buy Common Stock) · Derivative | 19,000 | $0.00 Strike: $9.55 | $0.00 |
DisclosureSEC source: 0001213900-25-120378 · ownership.xml · derivative · entry 4 Dillione Janet · CIK 0001489798 · Director 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 19,000 shares Expires 2026-02-21 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_date: These options were granted on 02/21/2016. These options are fully vested. Read SEC document |
| December 09, 2025 Filed Dec 11, 2025 08:38 UTC | CorMedix Inc. CRMD · Entity 5280 | SaleCommon Stock | 34,000 | $12.00 | $408,000.00 |
DisclosureSEC source: 0001213900-25-120378 · ownership.xml · nonDerivative · entry 3 Dillione Janet · CIK 0001489798 · Director 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 48,473 F1 · price: This transaction was executed in multiple trades at prices ranging from $12.00 to $12.02, inclusive. The price reported in Column 4 is a weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the Issuer or a security holder of the Issuer full information regarding the number of shares and prices at which the transactions were effected Read SEC document |
| December 09, 2025 Filed Dec 11, 2025 08:38 UTC | CorMedix Inc. CRMD · Entity 5280 | Exercise / conversionCommon Stock | 15,000 | $5.63 | $84,450.00 |
DisclosureSEC source: 0001213900-25-120378 · ownership.xml · nonDerivative · entry 2 Dillione Janet · CIK 0001489798 · Director 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 82,473 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| December 09, 2025 Filed Dec 11, 2025 08:38 UTC | CorMedix Inc. CRMD · Entity 5280 | Exercise / conversionCommon Stock | 19,000 | $9.55 | $181,450.00 |
DisclosureSEC source: 0001213900-25-120378 · ownership.xml · nonDerivative · entry 1 Dillione Janet · CIK 0001489798 · Director 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 67,473 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| December 02, 2025 Filed Dec 4, 2025 21:30 UTC | CorMedix Inc. CRMD · Entity 5280 | Exercise / conversionStock Option (Right to Buy Common Stock) · Derivative | 19,323 | $0.00 Strike: $3.55 | $0.00 |
DisclosureSEC source: 0001213900-25-118433 · ownership.xml · derivative · entry 7 Dillione Janet · CIK 0001489798 · Director 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 5,000 Underlying: Common Stock · 19,323 shares Expires 2034-03-05 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · derivative.exercise_date: These options were granted on 03/05/2024. These options are fully vested. Read SEC document |
| December 02, 2025 Filed Dec 4, 2025 21:30 UTC | CorMedix Inc. CRMD · Entity 5280 | Exercise / conversionStock Option (Right to Buy Common Stock) · Derivative | 15,124 | $0.00 Strike: $4.43 | $0.00 |
DisclosureSEC source: 0001213900-25-118433 · ownership.xml · derivative · entry 6 Dillione Janet · CIK 0001489798 · Director 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 15,124 shares Expires 2033-01-14 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_date: These options were granted on 01/14/2023. These options are fully vested. Read SEC document |
| December 02, 2025 Filed Dec 4, 2025 21:30 UTC | CorMedix Inc. CRMD · Entity 5280 | Exercise / conversionStock Option (Right to Buy Common Stock) · Derivative | 12,210 | $0.00 Strike: $4.03 | $0.00 |
DisclosureSEC source: 0001213900-25-118433 · ownership.xml · derivative · entry 5 Dillione Janet · CIK 0001489798 · Director 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 12,210 shares Expires 2032-02-22 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_date: These options were granted on 02/22/2022. These options are fully vested. Read SEC document |
| December 02, 2025 Filed Dec 4, 2025 21:30 UTC | CorMedix Inc. CRMD · Entity 5280 | SaleCommon Stock | 46,657 | $10.00 | $466,570.00 |
DisclosureSEC source: 0001213900-25-118433 · ownership.xml · nonDerivative · entry 4 Dillione Janet · CIK 0001489798 · Director 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 48,473 Read SEC document |
| December 02, 2025 Filed Dec 4, 2025 21:30 UTC | CorMedix Inc. CRMD · Entity 5280 | Exercise / conversionCommon Stock | 19,323 | $3.55 | $68,596.65 |
DisclosureSEC source: 0001213900-25-118433 · ownership.xml · nonDerivative · entry 3 Dillione Janet · CIK 0001489798 · Director 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 95,130 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| December 02, 2025 Filed Dec 4, 2025 21:30 UTC | CorMedix Inc. CRMD · Entity 5280 | Exercise / conversionCommon Stock | 15,124 | $4.43 | $66,999.32 |
DisclosureSEC source: 0001213900-25-118433 · ownership.xml · nonDerivative · entry 2 Dillione Janet · CIK 0001489798 · Director 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 75,807 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| December 02, 2025 Filed Dec 4, 2025 21:30 UTC | CorMedix Inc. CRMD · Entity 5280 | Exercise / conversionCommon Stock | 12,210 | $4.03 | $49,206.30 |
DisclosureSEC source: 0001213900-25-118433 · ownership.xml · nonDerivative · entry 1 Dillione Janet · CIK 0001489798 · Director 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 60,683 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| November 24, 2025 Filed Nov 26, 2025 21:30 UTC | CorMedix Inc. CRMD · Entity 5280 | Exercise / conversionStock Option (Right to Buy Common Stock) · Derivative | 5,677 | $0.00 Strike: $3.55 | $0.00 |
DisclosureSEC source: 0001213900-25-115725 · ownership.xml · derivative · entry 9 Dillione Janet · CIK 0001489798 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 24,323 Underlying: Common Stock · 5,677 shares Expires 2034-03-05 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F5 · derivative.exercise_date: These options were granted on 03/05/2024. These options are fully vested. Read SEC document |
| November 24, 2025 Filed Nov 26, 2025 21:30 UTC | CorMedix Inc. CRMD · Entity 5280 | Exercise / conversionStock Option (Right to Buy Common Stock) · Derivative | 4,876 | $0.00 Strike: $4.43 | $0.00 |
DisclosureSEC source: 0001213900-25-115725 · ownership.xml · derivative · entry 8 Dillione Janet · CIK 0001489798 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 15,124 Underlying: Common Stock · 4,876 shares Expires 2033-01-14 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F4 · derivative.exercise_date: These options were granted on 01/14/2023. These options are fully vested. Read SEC document |
| November 24, 2025 Filed Nov 26, 2025 21:30 UTC | CorMedix Inc. CRMD · Entity 5280 | Exercise / conversionStock Option (Right to Buy Common Stock) · Derivative | 7,790 | $0.00 Strike: $4.03 | $0.00 |
DisclosureSEC source: 0001213900-25-115725 · ownership.xml · derivative · entry 7 Dillione Janet · CIK 0001489798 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 12,210 Underlying: Common Stock · 7,790 shares Expires 2032-02-22 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · derivative.exercise_date: These options were granted on 02/22/2022. These options are fully vested. Read SEC document |
| November 24, 2025 Filed Nov 26, 2025 21:30 UTC | CorMedix Inc. CRMD · Entity 5280 | Exercise / conversionStock Option (Right to Buy Common Stock) · Derivative | 8,000 | $0.00 Strike: $2.85 | $0.00 |
DisclosureSEC source: 0001213900-25-115725 · ownership.xml · derivative · entry 6 Dillione Janet · CIK 0001489798 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 8,000 shares Expires 2028-02-16 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_date: These options were granted on 02/16/2018. These options are fully vested. Read SEC document |
| November 24, 2025 Filed Nov 26, 2025 21:30 UTC | CorMedix Inc. CRMD · Entity 5280 | SaleCommon Stock | 26,343 | $9.93 | $261,585.99 |
DisclosureSEC source: 0001213900-25-115725 · ownership.xml · nonDerivative · entry 5 Dillione Janet · CIK 0001489798 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 48,473 F1 · price: This transaction was executed in multiple trades at prices ranging from $9.72 to $10.00, inclusive. The price reported in Column 4 is a weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the Issuer or a security holder of the Issuer full information regarding the number of shares and prices at which the transactions were effected. Read SEC document |
| November 24, 2025 Filed Nov 26, 2025 21:30 UTC | CorMedix Inc. CRMD · Entity 5280 | Exercise / conversionCommon Stock | 5,677 | $3.55 | $20,153.35 |
DisclosureSEC source: 0001213900-25-115725 · ownership.xml · nonDerivative · entry 4 Dillione Janet · CIK 0001489798 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 74,816 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| November 24, 2025 Filed Nov 26, 2025 21:30 UTC | CorMedix Inc. CRMD · Entity 5280 | Exercise / conversionCommon Stock | 4,876 | $4.43 | $21,600.68 |
DisclosureSEC source: 0001213900-25-115725 · ownership.xml · nonDerivative · entry 3 Dillione Janet · CIK 0001489798 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 69,139 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| November 24, 2025 Filed Nov 26, 2025 21:30 UTC | CorMedix Inc. CRMD · Entity 5280 | Exercise / conversionCommon Stock | 7,790 | $4.03 | $31,393.70 |
DisclosureSEC source: 0001213900-25-115725 · ownership.xml · nonDerivative · entry 2 Dillione Janet · CIK 0001489798 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 64,263 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| November 24, 2025 Filed Nov 26, 2025 21:30 UTC | CorMedix Inc. CRMD · Entity 5280 | Exercise / conversionCommon Stock | 8,000 | $2.85 | $22,800.00 |
DisclosureSEC source: 0001213900-25-115725 · ownership.xml · nonDerivative · entry 1 Dillione Janet · CIK 0001489798 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 56,473 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| November 14, 2025 Filed Nov 18, 2025 21:45 UTC | CorMedix Inc. CRMD · Entity 5280 | SaleCommon Stock | 30,000 | $11.42 | $342,600.00 |
DisclosureSEC source: 0001213900-25-112316 · ownership.xml · nonDerivative · entry 1 Dillione Janet · CIK 0001489798 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 48,473 F1 · price: This transaction was executed in multiple trades at prices ranging from $11.41 to $11.44, inclusive. The price reported in Column 4 is a weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the Issuer or a security holder of the Issuer full information regarding the number of shares and prices at which the transactions were effected. Read SEC document |
| January 17, 2025 Filed Jan 22, 2025 21:08 UTC | CorMedix Inc. CRMD · Entity 5280 | GrantCommon Stock | 25,000 | $0.00 | $0.00 |
DisclosureSEC source: 0001213900-25-005672 · ownership.xml · nonDerivative · entry 1 Dillione Janet · CIK 0001489798 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 78,473 F1 · price: These shares represent restricted stock units issued on January 17, 2025. Each restricted stock unit represents the right to receive one share of CorMedix Inc. common stock. These restricted stock units will vest in full on January 17, 2026, subject to continued service on the vesting date. Read SEC document |
| March 05, 2024 Filed Mar 20, 2024 16:25 UTC | CorMedix Inc. CRMD · Entity 5280 | GrantStock Option (Right to Buy Common Stock) · Derivative | 30,000 | $0.00 Strike: $3.55 | $0.00 |
DisclosureSEC source: 0000899140-24-000323 · form4.xml · derivative · entry 1 Dillione Janet · CIK 0001489798 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 30,000 Underlying: Common Stock · 30,000 shares Expires 2034-03-05 F1 · derivative.exercise_date: These options were granted on 3/5/2024. The options vest monthly with full vesting on the one year anniversary of the date of grant, subject to continued service on the board. Read SEC document |
| January 14, 2023 Filed Jan 18, 2023 19:01 UTC | CorMedix Inc. CRMD · Entity 5280 | GrantStock Option (Right to Buy Common Stock) · Derivative | 20,000 | $0.00 Strike: $4.43 | $0.00 |
DisclosureSEC source: 0001213900-23-003554 · ownership.xml · derivative · entry 2 Dillione Janet · CIK 0001489798 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 20,000 Underlying: Common Stock · 20,000 shares Expires 2033-01-14 F1 · derivative.exercise_date: These options were granted on 1/14/2023. The options vest monthly with full vesting on the one year anniversary of the date of grant, subject to continued service on the board. Read SEC document |
| February 22, 2022 Filed Feb 23, 2022 17:43 UTC | CorMedix Inc. CRMD · Entity 5280 | GrantStock Option (Right to Buy Common Stock) · Derivative | 20,000 | $0.00 Strike: $4.03 | $0.00 |
DisclosureSEC source: 0000929638-22-000532 · form4.xml · derivative · entry 2 Dillione Janet · CIK 0001489798 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 20,000 Underlying: Common Stock · 20,000 shares Expires 2032-02-22 F9 · derivative.exercise_date: These options were granted on 2/22/2022. The options vest monthly with full vesting on the one year anniversary of the date of grant, subject to continued service on the board. Read SEC document |
| January 11, 2021 Filed Jan 13, 2021 20:16 UTC | CorMedix Inc. CRMD · Entity 5280 | GrantStock Option (Right to Buy Common Stock) · Derivative | 30,000 | $0.00 Strike: $8.32 | $0.00 |
DisclosureSEC source: 0001213900-21-002060 · doc4.xml · derivative · entry 2 Dillione Janet · CIK 0001489798 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 30,000 Underlying: Common Stock · 30,000 shares Expires 2031-01-11 F1 · derivative.exercise_date: These options were granted on 1/11/2021. The options vest monthly with full vesting on the one year anniversary of the date of grant, subject to continued service on the board. Read SEC document |
| November 16, 2020 Filed Nov 18, 2020 16:16 UTC | CorMedix Inc. CRMD · Entity 5280 | GrantPhantom Stock · Derivative | 3,583 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0001213900-20-037972 · doc4.xml · derivative · entry 2 Dillione Janet · CIK 0001489798 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 3,583 Underlying: Common Stock · 3,583 shares Expires not disclosed F1 · derivative.exercise_date: Each share of phantom stock is the economic equivalent of one share of common stock. The shares of phantom stock become payable in common stock on the tenth business day of January of the year following the reporting person's termination of service as a director. F1 · derivative.expiration_date: Each share of phantom stock is the economic equivalent of one share of common stock. The shares of phantom stock become payable in common stock on the tenth business day of January of the year following the reporting person's termination of service as a director. Read SEC document |
| August 14, 2020 Filed Aug 17, 2020 19:15 UTC | CorMedix Inc. CRMD · Entity 5280 | GrantPhantom Stock · Derivative | 4,770 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0001213900-20-022574 · doc4.xml · derivative · entry 2 Dillione Janet · CIK 0001489798 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 4,770 Underlying: Common Stock · 4,770 shares Expires not disclosed F1 · derivative.exercise_date: Each share of phantom stock is the economic equivalent of one share of common stock. The shares of phantom stock become payable in common stock on the tenth business day of January of the year following the reporting person's termination of service as a director. F1 · derivative.expiration_date: Each share of phantom stock is the economic equivalent of one share of common stock. The shares of phantom stock become payable in common stock on the tenth business day of January of the year following the reporting person's termination of service as a director. Read SEC document |
| May 15, 2020 Filed May 18, 2020 16:27 UTC | CorMedix Inc. CRMD · Entity 5280 | GrantPhantom Stock · Derivative | 5,253 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0001213900-20-012825 · doc4.xml · derivative · entry 2 Dillione Janet · CIK 0001489798 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 5,253 Underlying: Common Stock · 5,253 shares Expires not disclosed F1 · derivative.exercise_date: Each share of phantom stock is the economic equivalent of one share of common stock. The shares of phantom stock become payable in common stock on the tenth business day of January of the year following the reporting person's termination of service as a director. F1 · derivative.expiration_date: Each share of phantom stock is the economic equivalent of one share of common stock. The shares of phantom stock become payable in common stock on the tenth business day of January of the year following the reporting person's termination of service as a director. Read SEC document |
| February 25, 2020 Filed Feb 27, 2020 21:48 UTC | CorMedix Inc. CRMD · Entity 5280 | GrantStock Option (Right to Buy Common Stock) · Derivative | 15,000 | $5.63 Strike: $5.63 | $84,450.00 |
DisclosureSEC source: 0001213900-20-004981 · doc4.xml · derivative · entry 2 Dillione Janet · CIK 0001489798 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 15,000 Underlying: Common Stock · 15,000 shares Expires 2030-02-25 F1 · derivative.exercise_date: These options were granted on 02/25/2020. The options vest monthly with full vesting on the one year anniversary of the date of grant, subject to continued service on the board. Read SEC document |
| February 14, 2020 Filed Feb 19, 2020 16:18 UTC | CorMedix Inc. CRMD · Entity 5280 | GrantPhantom Stock · Derivative | 1,706 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0001213900-20-004256 · doc4.xml · derivative · entry 2 Dillione Janet · CIK 0001489798 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,706 Underlying: Common Stock · 1,706 shares Expires not disclosed F1 · derivative.exercise_date: Each share of phantom stock is the economic equivalent of one share of common stock. The shares of phantom stock become payable in common stock on the tenth business day of January of the year following the reporting person's termination of service as a director. F1 · derivative.expiration_date: Each share of phantom stock is the economic equivalent of one share of common stock. The shares of phantom stock become payable in common stock on the tenth business day of January of the year following the reporting person's termination of service as a director. Read SEC document |
| February 14, 2020 Filed Feb 20, 2020 17:05 UTC Amendment | CorMedix Inc. CRMD · Entity 5280 | GrantPhantom Stock · Derivative | 1,706 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0001213900-20-004441 · doc4.xml · derivative · entry 2 Dillione Janet · CIK 0001489798 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,706 Underlying: Common Stock · 1,706 shares Expires not disclosed F1 · derivative.exercise_date: Each share of phantom stock is the economic equivalent of one share of common stock. The shares of phantom stock become payable in common stock on the tenth business day of January of the year following the reporting person's termination of service as a director. F1 · derivative.expiration_date: Each share of phantom stock is the economic equivalent of one share of common stock. The shares of phantom stock become payable in common stock on the tenth business day of January of the year following the reporting person's termination of service as a director. Read SEC document |
| November 14, 2019 Filed Nov 18, 2019 17:21 UTC | CorMedix Inc. CRMD · Entity 5280 | GrantPhantom Stock · Derivative | 2,099 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0001213900-19-023937 · doc4.xml · derivative · entry 2 Dillione Janet · CIK 0001489798 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 2,099 Underlying: Common Stock · 2,099 shares Expires not disclosed F1 · derivative.exercise_date: Each share of phantom stock is the economic equivalent of one share of common stock. The shares of phantom stock become payable in common stock on the tenth business day of January of the year following the reporting person's termination of service as a director. F1 · derivative.expiration_date: Each share of phantom stock is the economic equivalent of one share of common stock. The shares of phantom stock become payable in common stock on the tenth business day of January of the year following the reporting person's termination of service as a director. Read SEC document |
| August 16, 2019 Filed Aug 16, 2019 16:07 UTC | CorMedix Inc. CRMD · Entity 5280 | PurchaseCommon Stock | 6,147 | $8.19 | $50,343.93 |
DisclosureSEC source: 0001213900-19-016167 · ownership.xml · nonDerivative · entry 1 Dillione Janet · CIK 0001489798 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 53,473 F1 · price: Represents the weighted average purchase price of the shares purchased ranging from a low of $8.179 to a high of $8.199 per share. Read SEC document |
| August 14, 2019 Filed Aug 16, 2019 16:07 UTC | CorMedix Inc. CRMD · Entity 5280 | GrantPhantom Stock · Derivative | 945 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0001213900-19-016167 · ownership.xml · derivative · entry 2 Dillione Janet · CIK 0001489798 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 945 Underlying: Common Stock · 945 shares Expires not disclosed F2 · derivative.exercise_date: Each share of phantom stock is the economic equivalent of one share of common stock. The shares of phantom stock become payable in common stock on the tenth business day of January of the year following the reporting person's termination of service as a director. F2 · derivative.expiration_date: Each share of phantom stock is the economic equivalent of one share of common stock. The shares of phantom stock become payable in common stock on the tenth business day of January of the year following the reporting person's termination of service as a director. Read SEC document |
| May 15, 2019 Filed May 17, 2019 09:24 UTC | CorMedix Inc. CRMD · Entity 5280 | GrantPhantom Stock · Derivative | 1,126 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0001654954-19-006225 · section16.xml · derivative · entry 2 Dillione Janet · CIK 0001489798 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 226 Underlying: Common Stock · 226 shares Expires not disclosed F2 · derivative.exercise_date: Each share of phantom stock is the economic equivalent of one share of common stock. The shares of phantom stock become payable in common stock on the tenth business day of January of the year following the reporting person's termination of service as a director. F2 · derivative.expiration_date: Each share of phantom stock is the economic equivalent of one share of common stock. The shares of phantom stock become payable in common stock on the tenth business day of January of the year following the reporting person's termination of service as a director. Read SEC document |
| May 15, 2019 Filed May 17, 2019 09:24 UTC | CorMedix Inc. CRMD · Entity 5280 | PurchaseCommon Stock | 11,144 | $6.74 | $75,110.56 |
DisclosureSEC source: 0001654954-19-006225 · section16.xml · nonDerivative · entry 1 Dillione Janet · CIK 0001489798 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 47,326 F1 · price: Represents the weighted average purchase price of the shares purchased from a low of $6.72 to a high of $6.74 per share. F8 · balance_after: The issuer effected a 1-for-5 reverse stock split on March 26, 2019. All share and per share amounts shown in this Form 4 have been adjusted to reflect the reverse stock split. Read SEC document |
| March 18, 2019 Filed Mar 20, 2019 16:21 UTC | CorMedix Inc. CRMD · Entity 5280 | PurchaseCommon Stock | 42,000 | $1.67 | $69,972.00 |
DisclosureSEC source: 0001654954-19-002991 · section16.xml · nonDerivative · entry 1 Dillione Janet · CIK 0001489798 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 180,909 F1 · price: Represents the weighted average purchase price of the shares purchased from a low of $1.655 to a high of $1.670 per share. Read SEC document |
| February 14, 2019 Filed Feb 19, 2019 16:02 UTC | CorMedix Inc. CRMD · Entity 5280 | GrantPhantom Stock · Derivative | 4,213 | $1.78 Strike: $0.00 | $7,499.14 |
DisclosureSEC source: 0001654954-19-001754 · section16.xml · derivative · entry 2 Dillione Janet · CIK 0001489798 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 4,213 Underlying: Common Stock · 4,213 shares Expires not disclosed F1 · derivative.exercise_date: Each share of phantom stock is the economic equivalent of one share of common stock. The shares of phantom stock become payable in common stock on the tenth business day of January of the year following the reporting person's termination of service as a director. F1 · derivative.expiration_date: Each share of phantom stock is the economic equivalent of one share of common stock. The shares of phantom stock become payable in common stock on the tenth business day of January of the year following the reporting person's termination of service as a director. Read SEC document |
| January 10, 2019 Filed Jan 11, 2019 16:10 UTC | CorMedix Inc. CRMD · Entity 5280 | GrantStock Option (Right to Buy Common Stock) · Derivative | 75,000 | $0.00 Strike: $1.66 | $0.00 |
DisclosureSEC source: 0001654954-19-000378 · section16.xml · derivative · entry 3 Dillione Janet · CIK 0001489798 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 75,000 Underlying: Common Stock · 75,000 shares Expires 2029-01-10 F2 · derivative.exercise_date: These options were granted on 01/10/2019. The options vest monthly with full vesting on the one year anniversary of the date of grant, subject to continued service on the board. Read SEC document |
| January 10, 2019 Filed Jan 11, 2019 16:10 UTC | CorMedix Inc. CRMD · Entity 5280 | GrantRestricted Stock Units | 5,000 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001654954-19-000378 · section16.xml · nonDerivative · entry 2 Dillione Janet · CIK 0001489798 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 138,909 F1 · price: These shares consist of restricted stock units granted on 01/10/2019. These restricted stock units will vest monthly with full vesting on the first anniversary of the date of grant, subject to continued service on the board. Read SEC document |
| January 10, 2019 Filed Jan 11, 2019 16:10 UTC | CorMedix Inc. CRMD · Entity 5280 | GrantRestricted Stock Units | 12,500 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001654954-19-000378 · section16.xml · nonDerivative · entry 1 Dillione Janet · CIK 0001489798 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 133,909 F1 · price: These shares consist of restricted stock units granted on 01/10/2019. These restricted stock units will vest monthly with full vesting on the first anniversary of the date of grant, subject to continued service on the board. Read SEC document |
| November 14, 2018 Filed Nov 16, 2018 16:07 UTC | CorMedix Inc. CRMD · Entity 5280 | GrantPhantom Stock · Derivative | 6,637 | $1.13 Strike: $0.00 | $7,499.81 |
DisclosureSEC source: 0001654954-18-012892 · section16.xml · derivative · entry 2 Dillione Janet · CIK 0001489798 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 6,637 Underlying: Common Stock · 6,637 shares Expires not disclosed F1 · derivative.exercise_date: Each share of phantom stock is the economic equivalent of one share of common stock. The shares of phantom stock become payable in common stock on the tenth business day of January of the year following the reporting person's termination of service as a director. F1 · derivative.expiration_date: Each share of phantom stock is the economic equivalent of one share of common stock. The shares of phantom stock become payable in common stock on the tenth business day of January of the year following the reporting person's termination of service as a director. Read SEC document |
| November 14, 2018 Filed Nov 30, 2018 16:21 UTC Amendment | CorMedix Inc. CRMD · Entity 5280 | GrantPhantom Stock · Derivative | 6,637 | $1.13 Strike: $0.00 | $7,499.81 |
DisclosureSEC source: 0001654954-18-013416 · section16.xml · derivative · entry 2 Dillione Janet · CIK 0001489798 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 6,637 Underlying: Common Stock · 6,637 shares Expires not disclosed F2 · derivative.exercise_date: Each share of phantom stock is the economic equivalent of one share of common stock. The shares of phantom stock become payable in common stock on the tenth business day of January of the year following the reporting person's termination of service as a director. F2 · derivative.expiration_date: Each share of phantom stock is the economic equivalent of one share of common stock. The shares of phantom stock become payable in common stock on the tenth business day of January of the year following the reporting person's termination of service as a director. Read SEC document |
| August 14, 2018 Filed Aug 16, 2018 16:01 UTC | CorMedix Inc. CRMD · Entity 5280 | GrantPhantom Stock · Derivative | 13,636 | $0.55 Strike: $0.00 | $7,499.80 |
DisclosureSEC source: 0001654954-18-009262 · section16.xml · derivative · entry 2 Dillione Janet · CIK 0001489798 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 13,636 Underlying: Common Stock · 13,636 shares Expires not disclosed F1 · derivative.exercise_price: Each share of phantom stock is the economic equivalent of one share of common stock. The shares of phantom stock become payable in common stock on the tenth business day of January of the year following the reporting person's termination of service as a director. F1 · derivative.exercise_date: Each share of phantom stock is the economic equivalent of one share of common stock. The shares of phantom stock become payable in common stock on the tenth business day of January of the year following the reporting person's termination of service as a director. F1 · derivative.expiration_date: Each share of phantom stock is the economic equivalent of one share of common stock. The shares of phantom stock become payable in common stock on the tenth business day of January of the year following the reporting person's termination of service as a director. Read SEC document |
| May 15, 2018 Filed May 17, 2018 16:01 UTC | CorMedix Inc. CRMD · Entity 5280 | GrantPhantom Stock · Derivative | 37,500 | $0.20 Strike: $0.00 | $7,500.00 |
DisclosureSEC source: 0001654954-18-005595 · section16.xml · derivative · entry 2 Dillione Janet · CIK 0001489798 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 37,500 Underlying: Common Stock · 37,500 shares Expires not disclosed F1 · derivative.exercise_price: Each share of phantom stock is the economic equivalent of one share of common stock. The shares of phantom stock become payable in common stock on the tenth business day of January of the year following the reporting person's termination of service as a director. F1 · derivative.exercise_date: Each share of phantom stock is the economic equivalent of one share of common stock. The shares of phantom stock become payable in common stock on the tenth business day of January of the year following the reporting person's termination of service as a director. F1 · derivative.expiration_date: Each share of phantom stock is the economic equivalent of one share of common stock. The shares of phantom stock become payable in common stock on the tenth business day of January of the year following the reporting person's termination of service as a director. Read SEC document |
| February 21, 2018 Filed Mar 22, 2018 16:01 UTC | CorMedix Inc. CRMD · Entity 5280 | Exercise / conversionRestricted Stock Units · Derivative | 15,357 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0001654954-18-002932 · section16.xml · derivative · entry 2 Dillione Janet · CIK 0001489798 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 15,357 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_date: These Restricted Stock Units were granted on 2/21/2017. Each restricted stock unit represents the right to receive one share of CorMedix Inc. common stock. The restricted stock vested in full on the first anniversary of the date of grant, which was February 21, 2018. F1 · derivative.expiration_date: These Restricted Stock Units were granted on 2/21/2017. Each restricted stock unit represents the right to receive one share of CorMedix Inc. common stock. The restricted stock vested in full on the first anniversary of the date of grant, which was February 21, 2018. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.